Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.43M Hold
150,000
– – ﹤0.01% 2805
2026
Q2
$1.99M Hold
150,000
– – ﹤0.01% 2342
2026
Q1
$2.57M Buy
+150,000
New +$2.78M ﹤0.01% 2202
2025
Q4
– Sell
-200,000
Closed -$4.68M – 5764
2025
Q3
$4.68M Buy
+200,000
New +$4.01M ﹤0.01% 2255
2024
Q4
– Sell
-100,000
Closed -$1.22M – 5516
2024
Q3
$1.22M Buy
+100,000
New +$829K ﹤0.01% 3231
2024
Q1
– Sell
-65,000
Closed -$948K – 5415
2023
Q4
$948K Buy
+65,000
New +$1.03M ﹤0.01% 3469
2023
Q2
– Sell
-241,600
Closed -$2.68M – 5145
2023
Q1
$2.68M Sell
241,600
-479,800
-67% -$4.64M ﹤0.01% 1969
2022
Q4
$7.17M Buy
+721,400
New +$6.5M ﹤0.01% 1391

Other funds holding XPEV

Barclays's XPEV Position: Q3 2026 in Review

Barclays increased its XPeng (XPEV) stake by 11% in Q3 2026, buying an estimated $1.84M and bringing the position to 1,618,416 shares worth $15.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1397.

Barclays first reported a position in XPEV in Q1 2022 and has held it in 19 quarters since. The position peaked at $30.6M in Q1 2022. 169 funds tracked by Wall St. Rank hold XPEV as of Q3 2026.

  • Barclays held 1,618,416 shares of XPeng worth $15.5M as of Q3 2026.
  • Barclays bought 155,377 XPeng shares in Q3 2026, an estimated $1.84M.
  • XPeng made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #1397 holding.
  • Barclays first reported a position in XPeng in Q1 2022 and has held it in 19 quarters since.
  • Barclays's XPeng position peaked at $30.6M in Q1 2022.
  • 169 funds tracked by Wall St. Rank held XPeng as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.